BRAF and NRAS mutations are associated with poor prognosis in Asians with acral-lentiginous and nodular cutaneous melanoma

被引：0

作者：

Cahyono, R. ^{[1
]}

Anwar, S. L. ^{[1
]}

Pradana, G. D. ^{[1
]}

Boediman, H. Y. ^{[1
]}

机构：

[1] Gadjah Mada Univ, Dr Sardjito Gen Hosp, Surg Dept, Surg Oncol, Yogyakarta, Indonesia

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.321

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

606P

引用

页码：S1709 / S1710

页数：2

共 50 条

[31] Acral Lentiginous Melanoma Is Associated with Certain Poor Prognostic Histopathological Factors but May Not be Correlated with Nodal Involvement, Recurrence, and a Worse Survival
Tas, Faruk
Erturk, Kayhan
PATHOBIOLOGY, 2018, 85 (04) : 227 - 231
[32] KRAS/NRAS Mutations Associated with Distant Metastasis and BRAF/PIK3CA Mutations Associated with Poor Tumor Differentiation in Colorectal Cancer
Zeng, Juanzi
Fan, Wenwei
Li, Jiaquan
Wu, Guowu
Wu, Heming
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4109 - 4120
[33] Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
Einar Birkeland
Christian Busch
Elisabet Ognedal Berge
Jürgen Geisler
Göran Jönsson
Johan Richard Lillehaug
Stian Knappskog
Per Eystein Lønning
Clinical & Experimental Metastasis, 2013, 30 : 867 - 876
[34] Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma
Birkeland, Einar
Busch, Christian
Berge, Elisabet Ognedal
Geisler, Jurgen
Jonsson, Goran
Lillehaug, Johan Richard
Knappskog, Stian
Lonning, Per Eystein
CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (07) : 867 - 876
[35] Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
Sheen, Yi-Shuan
Liao, Yi-Hua
Lin, Ming-Hsien
Chiu, Hsien-Ching
Jee, Shiou-Hwa
Liau, Jau-Yu
Chang, Yih-Leong
Chu, Chia-Yu
PLOS ONE, 2016, 11 (01):
[36] NRAS and BRAF Mutations in Cutaneous Melanoma and the Association with MC1R Genotype: Findings from Spanish and Austrian Populations
Hacker, Elke
Nagore, Eduardo
Cerroni, Lorenzo
Woods, Susan L.
Hayward, Nicholas K.
Chapman, Brett
Montgomery, Grant W.
Soyer, H. Peter
Whiteman, David C.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 (04) : 1027 - 1033
[37] TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma
Campos, Manuel Antonio
Macedo, Sofia
Fernandes, Margarida
Pestana, Ana
Pardal, Joana
Batista, Rui
Vinagre, Joao
Sanches, Agostinho
Baptista, Armando
Lopes, Jose Manuel
Soares, Paula
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (03) : 660 - +
[38] AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy
Anton Puig-Butille, Joan
Vinyals, Antonia
Ferreres, Josep R.
Aguilera, Paula
Cabre, Eduard
Tell-Marti, Gemma
Marcoval, Joaquim
Mateo, Francesca
Palomero, Luis
Badenas, Celia
Piulats, Josep M.
Malvehy, Josep
Pujana, Miquel A.
Puig, Susana
Fabra, Angels
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (06) : 1297 - 1310
[39] Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
Elisabetta Macerola
Barbara Loggini
Riccardo Giannini
Giulia Garavello
Mirella Giordano
Agnese Proietti
Cristina Niccoli
Fulvio Basolo
Gabriella Fontanini
Virchows Archiv, 2015, 467 : 177 - 184
[40] Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness
Macerola, Elisabetta
Loggini, Barbara
Giannini, Riccardo
Garavello, Giulia
Giordano, Mirella
Proietti, Agnese
Niccoli, Cristina
Basolo, Fulvio
Fontanini, Gabriella
VIRCHOWS ARCHIV, 2015, 467 (02) : 177 - 184

← 1 2 3 4 5 →